COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases

Ann Rheum Dis. 2021 Apr;80(4):e50. doi: 10.1136/annrheumdis-2020-218008. Epub 2020 Jun 5.

Authors

Clementina López-Medina^{1

2

3

4}, Alejandro Escudero^{5

2

3}, Eduardo Collantes-Estevez^{5

2

3}

Affiliations

¹ Rheumatology Department, Reina Sofía University Hospital, Córdoba, Spain clementinalopezmedina@gmail.com.
² GC05 group, Maimónides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain.
³ Medicine Department, University of Córdoba, Córdoba, Spain.
⁴ Rheumatology Department, Cochin Hospital, Paris, France.
⁵ Rheumatology Department, Reina Sofía University Hospital, Córdoba, Spain.

PMID: 32503860
DOI: 10.1136/annrheumdis-2020-218008

No abstract available

Keywords: outcome and process assessment, health care; outcome assessment, health care; quality indicators, health care.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Pandemics
Rheumatic Diseases* / therapy
SARS-CoV-2
Telemedicine*